CEL-SCI Corporation - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CVM NYSE American 2830 cel-sci.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CEL-SCI Corporation

CEL-SCI Reports Fiscal Third Quarter 2026 Results - Aug 17th, 2026 6:30 am
CEL-SCI Study Published in Peer-Reviewed Oral Oncology Supports Multikine's Biomarker Strategy and Potential Overall Survival Benefit Ahead of Head and Neck Cancer Confirmatory Registration Study - Aug 4th, 2026 6:00 am
Leading Oncology Journal Accepts For Publication New CEL-SCI Multikine Phase 3 Data Demonstrating Overall Survival Benefit in Underserved Head and Neck Cancer Patients - Jul 30th, 2026 6:31 am
CEL-SCI to Launch FDA Registration-Enabling Phase 3 Confirmatory Study to Bring Multikine® to Market for Newly Diagnosed Head and Neck Cancer - Jul 13th, 2026 6:00 am
CEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.–Saudi Cooperation in Cancer Care - Jun 24th, 2026 6:00 am
CEL-SCI Announces Closing of Offering - Jun 16th, 2026 2:01 pm
CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy - Jun 16th, 2026 6:00 am
CVM Stock Sinks In Pre-Market Trading After Announcing Second Equity Raise For Its Cancer Drug In Just Over A Month - Jun 15th, 2026 5:12 am
CEL-SCI Corporation Announces Pricing of Offering - Jun 14th, 2026 5:03 pm
CEL-SCI and Saudi Amarox to Conduct Signing Ceremony at BIO 2026 for Strategic Agreement to Advance Commercialization and Distribution of Multikine® in Saudi Arabia - Jun 12th, 2026 6:00 am
CEL-SCI Presentation at LD Micro "Main Event" Available on Tuesday, October 21, 2025 - Oct 20th, 2025 7:00 am
CEL-SCI Corporation to Present at LD Micro "Main Event" Investor Conference - Oct 10th, 2025 6:00 am